Compared to the control tumour tissue, protein levels of GRASP55 and β‐catenin were significantly elevated in oxaliplatin‐treated tumour, whereas monotherapy of CEC‐sEVs did not affect these two protein levels (Figure 9fh). The gene discussed is GORASP2; the disease is neoplasm.